Genomics, proteomics and bioinformatics of human heart failure.
about
The use of proteomics to identify novel therapeutic targets for the treatment of disease.Recent advances in biomarker discovery in solid organ transplant by proteomics.Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue.Chipping into the human genome: novel insights for transplantation.A proteomic primer for the clinicianBiomarkers and updates on pediatrics lupus nephritis.The role of proteomics in clinical cardiovascular biomarker discovery.Methodology and applications of disease biomarker identification in human serum.Protein and peptide biomarkers in organ transplantation.Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses.The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease.Postmyocardial infarct remodeling and heart failure: potential contributions from pro- and antiaging factors.Analyzing the cardiac muscle proteome by liquid chromatography-mass spectrometry-based expression proteomics.Proteomic analysis reveals different protein changes during endothelin-1- or leukemic inhibitory factor-induced hypertrophy of cardiomyocytes in vitro.Proteomes, Their Compositions and Their Sources.A new approach for the identification of modifier genes in heart failure
P2860
Q30361936-AE65F38D-3E29-4D86-8AF5-950A9B684619Q35764483-D8F0CEE4-2652-4B2A-985B-B5C5964AF318Q36175267-B24BA082-6237-40CE-A222-C3E0D1113866Q36453368-6377EE90-139D-466C-ACE7-17A7F6EE31C6Q36698789-A0696719-8A34-4440-9FD5-D1D59305DB1DQ37167062-D63020E6-5F44-4BD8-8C4D-5174422C0082Q37230702-6A29750F-8C9A-4120-8C6B-E583407EB6B5Q37574961-937D8809-EAA0-4EC3-9C38-3096606A35C4Q38021513-9054E9A7-3EF7-4A9B-89DF-4057DA144D9CQ38295801-81FB131C-13D2-463B-8709-BE740B5BC222Q41579484-CD863A1C-3DEA-4577-8762-3F0EADC80D55Q42011791-E9635E99-F09D-45E3-A43C-08921B1504E6Q42937888-C59398D9-4588-48C6-948F-2F36A5B5EA5FQ50486074-48B99D20-20D2-4861-9035-3EF354658E32Q51263649-C4515EB9-CDF6-4D02-8B16-7F1B363D3185Q57907328-DC991EE2-03F6-4484-BF3D-3A4A6D2BEFAC
P2860
Genomics, proteomics and bioinformatics of human heart failure.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Genomics, proteomics and bioinformatics of human heart failure.
@ast
Genomics, proteomics and bioinformatics of human heart failure.
@en
Genomics, proteomics and bioinformatics of human heart failure.
@nl
type
label
Genomics, proteomics and bioinformatics of human heart failure.
@ast
Genomics, proteomics and bioinformatics of human heart failure.
@en
Genomics, proteomics and bioinformatics of human heart failure.
@nl
prefLabel
Genomics, proteomics and bioinformatics of human heart failure.
@ast
Genomics, proteomics and bioinformatics of human heart failure.
@en
Genomics, proteomics and bioinformatics of human heart failure.
@nl
P2093
P2860
P356
P1476
Genomics, proteomics and bioinformatics of human heart failure.
@en
P2093
C G Dos Remedios
J E Van Eyk
R L Winslow
P2860
P2888
P304
P356
10.1023/A:1025433721505
P577
2003-01-01T00:00:00Z
P5875
P6179
1030993574